Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

The Endocannabinoid System in Local and Systemic Inflammation

BuchKartoniert, Paperback
Englisch
Morgan & Claypool Life Scienceserschienen am30.03.2017
Focuses on the role of the endocannabinoid system in local and systemic inflammation, with individual chapters written by experts in the field of cannabinoid research and medicine. The topics explore the actions of the endocannabinoid system on the immune system, including neuroinflammation in autoimmune disorders and in neurodegenerative disorders.mehr

Produkt

KlappentextFocuses on the role of the endocannabinoid system in local and systemic inflammation, with individual chapters written by experts in the field of cannabinoid research and medicine. The topics explore the actions of the endocannabinoid system on the immune system, including neuroinflammation in autoimmune disorders and in neurodegenerative disorders.
Details
ISBN/GTIN978-1-61504-748-2
ProduktartBuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2017
Erscheinungsdatum30.03.2017
SpracheEnglisch
MasseBreite 191 mm, Höhe 235 mm, Dicke 12 mm
Gewicht399 g
Artikel-Nr.42860410
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
PrefaceInflammation and the Endocannabinoid SystemCannabinoids in Multiple SclerosisHuntington's Disease and the Endocannabinoid SystemAlzheimer's, Neuroinflammation and the Endocannabinoid SystemThe Endocannabinoid System's Role in Ocular InflammationCannabidiol as a Potential Clinical Therapeutic Agent for the Reduction of Pancreatic Inflammation in Early Type 1 Diabetes MellitusRole of the Endocannabinoid System in Interstitial CystitisArthritis and the Endocannabinoid SystemCannabinoid 2 Receptor Activation in SepsisImmune Modulation by Cannabinoids During Central Nervous System Injury-induced NeuroinflammationLead Author BiographiesContributing Author BiographiesReferencesmehr

Autor

Melanie E.M. Kelly, Ph.D., is Professor of Pharmacology, Ophthalmology and Visual Sciences, and Anesthesia, Perioperative Medicine and Pain Management at Dalhousie University. Professor Kelly received her B.Sc. (Hons) in Physiology and Pharmacology from Southampton University, UK, in 1981 and, in 1984, completed a Ph.D. in Neurophysiology at Southampton University. Professor Kelly's research is in molecular and translational pharmacology, with expertise in G protein coupled receptors and ocular and vascular pharmacology. During the last decade, her research has centered on the pharmacology of the endocannabinoid system. Her laboratory, together with collaborators, has published ground breaking research on the role of the endocannabinoid system in ocular disease and the therapeutic potential of cannabinoid-based drugs. Professor Kelly is actively engaged in "bench to bedside" research to identify novel drug targets and bring new cannabinoid-based medications to the clinic to treat human disease. She has published over 120 scientific peer-reviewed papers, reviews, book chapters, and books, and is an inventor on patents to use cannabinoid-based drugs to treat inflammatory disease and neuropathic pain. Professor Kelly's research is funded by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the National Institutes of Health, USA. Professor Kelly is also one of the founders of a Nova Scotia-based biopharmaceutical company that is developing phytocannabinoid therapies to treat human inflammation and chronic pain and she is on the Executive Board of the Canadian Consortium for the Investigation of Cannabinoids (CCIC). She is a licensed National Pro-rally Codriver and enjoys running and hiking the beautiful Nova Scotia Coast.
Weitere Artikel von
Kelly, Melanie E. M.